Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Charles River Laboratories International, Inc. (CRL) had Consolidated Net Income/Loss of $-14.80M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$995.83M |
|
$-14.84M |
|
$701.17M |
|
$294.66M |
|
$875.93M |
|
$119.90M |
|
$-149.84M |
|
$-29.94M |
|
$-29.94M |
|
$-14.80M |
|
$-14.80M |
|
|
Consolidated Net Income/Loss |
$-14.80M |
$-14.80M |
|
$119.90M |
|
$187.05M |
|
48.95M |
|
48.95M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$1.49B |
|
$1.51B |
|
$6.24B |
|
$7.73B |
|
$1.09B |
|
$2.66B |
|
$3.69B |
|
$4.78B |
|
$2.95B |
|
$-342.61M |
|
$2.95B |
|
48.17M |
|
| Cash Flow Statement Financials | |
$41.08M |
|
$-407.85M |
|
$347.72M |
|
$216.00M |
|
$198.20M |
|
$-17.80M |
|
$22.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.36 |
|
-- |
|
-- |
|
0.47 |
|
0.90 |
|
29.59% |
|
12.04% |
|
12.04% |
|
-- |
|
-3.01% |
|
-1.49% |
|
$-14.83M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
1.95 |
|
1.42 |
|
63.29 |
|
-0.50% |
|
4.32% |
|
-0.19% |
|
-0.26% |
|
$61.17 |
|
$-0.30 |
|
$0.84 |
|